A dose-escalation and pharmacokinetic study of subcutaneously administered recombinant human interleukin 12 and its biological effects in Japanese patients with advanced malignancies.

Source:http://linkedlifedata.com/resource/pubmed/id/10914707

Download in:

View as

General Info

PMID
10914707